IL16 and gastric cancer: • Increased miR-128-3p expression decreases CD4+ regulatory T cells enrichment.• IL16 promotes CD4+ regulatory T cells enrichment.• miR-128-3p affects the proportion of CD4+ regulatory T cells by targeting IL16 in gastric cancer.